Home / Healthcare / US Market Changes in the Treatment of Advanced Melanoma

US Market Changes in the Treatment of Advanced Melanoma

Published: Sep 2012 | No Of Pages: 31 | Published By: Assessment Group
Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the factors that influence those decisions. Data presented includes oncologist treatment regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. 
This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.

Chapter 1: Introduction 5

Chapter 2: Respondent Demographics 6

Chapter 3: Treatment of Stage III Melanoma with Micrometastatic Axillary Nodes 8

Chapter 4: Treatment of Elderly Woman with Metastatic Disease at the Time of Diagnosis 14

Chapter 5: Young Man with Recurrent Melanoma Metastatic to Liver and Bone 18

Chapter 6: Patient with Solitary Metastatic Lesion 22

Appendix A: Survey Instrument 26
Choose License Type
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +